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Abstract
K-Tocopherol inhibits glutathione S-transferase P1-1 (GST P1-1) (R.I.M. van Haaften, C.T.A. Evelo, G.R.M.M. Haenen,
A. Bast, Biochem. Biophys. Res. Commun. 280 (2001)). In various cosmetic and dietary products K-tocopherol is added as a
tocopherol ester. Therefore we have studied the effect of various tocopherol derivatives on GST P1-1 activity. It was found
that GST P1-1 is inhibited, in a concentration dependent manner, by these compounds. Of the compounds tested, the
tocopherols were the most potent inhibitors of GST P1-1; the concentration giving 50% inhibition (IC50) is 6 1 WM. The
esterified tocopherols and K-tocopherol quinone also inhibit the GST P1-1 activity at a very low concentration: for most
compounds the IC50 was below 10 WM. RRR-K-Tocopherol acetate lowered the Vmax values, but did not affect the Km for
either 1-chloro-2,4-dinitrobenzene or GSH. This indicates that the GST P1-1 enzyme is non-competitively inhibited by RRR-
K-tocopherol acetate. The potential implications of GST P1-1 inhibition by tocopherol and K-tocopherol derivatives are
discussed. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Glutathione S-transferases (GSTs) are a family of
phase II detoxi¢cation enzymes that catalyze the
conjugation of glutathione (GSH) to electrophiles.
Numerous compounds are known to inhibit the
GST activity. Recently, we reported that K-tocopher-
ol is a potent inhibitor of the P1-1 isoform of GST
[1].
Vitamin E is a generic name for all tocol and to-
cotrienol derivatives. The antioxidant activity is the
most studied biological activity of these compounds
discovered thus far, although other activities have
also been found [2,3].
The tocopherols can be viewed as consisting of a
chroman head consisting of two rings (one phenolic
and one heterocyclic) and a phytyl tail. The phytyl
tail has three chiral centers (at positions 2, 4P and 8P),
making a total of eight stereoisomeric forms possible
(Fig. 1). The phytyl chain of naturally occurring to-
copherols (K-, L-, Q-, and N-tocopherol) has the RRR
con¢guration. A synthetic tocopherol usually is a
mixture of approximately equal amounts of the eight
stereoisomers (RRR, RRS, RSR, RSS, SRR, SRS,
SSR and SSS). This mixture is denoted as all-rac-
tocopherol [4].
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In the antioxidant activity of tocopherol, the free
aromatic hydroxyl group plays an essential role: the
tocopherol can donate its phenolic hydrogen to lipid
free radicals. Sequestration of this group inhibits the
antioxidant activity but also makes the molecule less
vulnerable to oxidation [4]. Therefore forms of K-
tocopherol have been developed in which the free
hydroxyl group has been blocked, e.g. by esteri¢ca-
tion of this alcoholic group with acetate or succinate.
In vivo, the ester is saponi¢ed by an esterase reveal-
ing the antioxidant activity.
The aim of this study is to investigate whether
tocopherols and K-tocopherol derivatives, other
than K-tocopherol, can inhibit GST P1-1.
2. Materials and methods
2.1. Chemicals
The compounds tested were: RRR-K-tocopherol,
all-rac-K-tocopherol, RRR-N-tocopherol, RRR-K-to-
copherol quinone, all-rac-K-tocopherol phosphate,
RRR-K-tocopherol succinate, all-rac-K-tocopherol
nicotinate, RRR-K-tocopherol acetate, all-rac-K-toco-
pherol acetate, arachidonic acid and trolox (6-hy-
droxy-2,5,7,8-tetramethyl-chroman-2-carboxylic
acid). All compounds were purchased from Sigma
(St. Louis, MO, USA), except RRR-K-tocopherol
quinone. This compound was synthesized from
RRR-K-tocopherol by oxidation with ferric chloride,
according to Cohen et al. [5]. 1-Chloro-2,4-dinitro-
benzene (CDNB) and GST P1-1 (from human pla-
centa) were also obtained from Sigma. GSH was
obtained from ICN Biomedicals (Costa Mesa, CA,
USA). All other chemicals were of analytical grade
purity.
2.2. Assay of glutathione S-transferase activity
GST activity was measured as described by Man-
nervik and Guthenberg [6] with slight modi¢cations.
In short, the reaction of 1 mM CDNB with 1 mM
GSH in 100 mM potassium phosphate, pH 6.5, at
37³C was monitored spectrophotometrically by re-
cording the increase in absorbance at 340 nm. E¡ects
of various concentrations of test compound on GST
activity were determined. A stock solution of test
compound was prepared in ethanol. The ¢nal con-
centration of ethanol in the incubation mixture was
1% v/v; this concentration of ethanol had no e¡ect
on GST activity. The mixture of the GST enzyme
(0.0095 U/ml in bu¡er) with test compound was in-
cubated for 2 min at 37³C before activity measure-
ment. A correction for the spontaneous formation of
the conjugate of GSH and CDNB in the absence of
enzyme and in the presence of ethanol (1%) was
made. To study the inhibitory mechanism of RRR-
K-tocopherol acetate, substrate concentrations
(CDNB or GSH) were varied. When CDNB was
varied the GSH concentration was kept at 1 mM
and vice versa. In these experiments the concentra-
tion RRR-K-tocopherol acetate was kept constant at
12.5 WM.
3. Results and discussion
All compounds tested (Fig. 1), except trolox and
arachidonic acid, were found to inhibit human GST
P1-1 activity towards CDNB at relatively low con-
centrations. An example of an inhibition curve at
increasing concentration of test compound is given
in Fig. 2 for RRR-K-tocopherol acetate.
The data in Fig. 1 show that both K-tocopherol
and N-tocopherol are very potent inhibitors of the
P1-1 isoform of GST. The IC50 of K-tocopherol
and N-tocopherol are 0.7 WM and 0.8 WM respec-
tively, indicating that there is practically no di¡er-
ence in potency between the K and the N isoform.
These two isoforms of tocopherol di¡er in the meth-
ylation pattern in the phenolic ring of the chroman
head (Fig. 1) [4]. From this it can be concluded that
methylation at positions 5 and 7 in the chroman
head of tocopherol has no in£uence on the GST
P1-1 inhibitory capacity.
From the results it also appears that sequestration
of the hydroxyl group in the chroman head of the
tocopherol molecule by acetate, succinate, phosphate
or nicotinate lowers the GST P1-1 inhibitory ca-
pacity, although the compounds are still potent in-
hibitors (Fig. 1). Fig. 1 also shows that the oxidation
product of K-tocopherol, K-tocopherol quinone (IC50
is 2.2 WM), is also active but has a lower inhibitory
e¡ect than the parent compound. The inhibitory po-
tency of trolox was low; even at 50 WM no substan-
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Fig. 1. Chemical structures of the compounds tested with the corresponding IC50 values. The three chiral centers in the phytyl tail are
indicated with * in K-tocopherol. Of K-tocopherol and K-tocopherol acetate both the RRR and the all-rac forms are tested. IC50 val-
ues indicate means ( þ S.E.M.) of three independent experiments each performed in duplicate.
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tial inhibition of GST P1-1 activity was observed.
This molecule has the same chroman ring as K-toco-
pherol; however, the phytyl chain is replaced by a
negatively charged carboxylate group (Fig. 1). Based
on these results we can conclude that the free aro-
matic hydroxyl group is not essential, while the phy-
tyl tail probably has a major contribution to GST
P1-1 inhibition. Thus other structural elements play a
role in GST inhibition than in free radical scavenging
in which the free hydroxyl group is important.
The IC50 values of the acetate esters of RRR-K-
tocopherol and all-rac-K-tocopherol are 9.1 WM and
5.2 WM respectively. This implies that at least one
stereoisomer of the all-rac-K-tocopherol acetate mol-
ecule inhibits GST P1-1 activity with higher potency
than the RRR-K-tocopherol acetate. So the sterical
orientation in the phytyl tail of the K-tocopherol
acetate molecule seems to be important for the
GST P1-1 inhibitory capacity. However, the RRR-
K-tocopherol and the all-rac-K-tocopherol exhibit
the same GST P1-1 inhibitory capacity; the IC50 of
the RRR-K-tocopherol and the all-rac-K-tocopherol
are 0.70 WM and 0.74 WM respectively. This indicates
that the mean inhibitory capacity of all K-tocopherol
stereoisomers is identical to that of RRR-K-tocopher-
ol. In vivo, RRR-K-tocopherol has a greater bioavail-
ability compared to the other stereoisomers [7] and
the e¡ect of this isomer might therefore still be the
most important when a racemic mixture is given.
From the results it also appears that arachidonic
acid inhibits the GST P1-1 activity with an IC50 val-
ue of 40.5 WM, much higher than for the tocopherols.
So not all compounds with a long hydrophobic
group inhibit the GST P1-1 activity at relatively
low concentrations. Arachidonic acid is known to
be a potent inhibitor of other GST isoenzymes. Mi-
tra et al. [8] used a crude GST fraction from rat liver
and found an IC50 of 17 WM, which is lower than the
IC50 we found for GST P1-1 in this study.
For the compound RRR-K-tocopherol acetate the
nature of the inhibition was also studied. GST activ-
ity was measured with variable concentrations of ei-
ther CDNB (insert Fig. 1) or GSH (data not shown)
in the presence of a ¢xed concentration RRR-K-to-
copherol acetate. RRR-K-Tocopherol acetate lowered
the Vmax values, but did not a¡ect the Km (approx.
1 mM). This means that RRR-K-tocopherol acetate,
like RRR-K-tocopherol [1], exhibits a non-competi-
tive inhibition with respect to the substrates CDNB
and GSH.
Fig. 2. E¡ect of RRR-K-tocopherol acetate on the activity of GST P1-1. The GST activity was measured by following the reaction be-
tween 1 mM glutathione and 1 mM 1-chloro-2,4-dinitrobenzene in 100 mM potassium phosphate, pH 6.5 at 37³C. Each point denotes
the mean ( þ S.E.M.) of three independent experiments each performed in triplicate. (Insert) Lineweaver^Burk plot showing non-com-
petitive inhibition of human placenta GST P1-1 isoenzyme towards CDNB by 12.5 WM RRR-K-tocopherol acetate. The Km and Vmax
(mean þ range) of two independent experiments performed in triplicate for CDNB (b) are respectively 1.13 þ 0.23 mM and
19.71 þ 3.49 Wmol/minWmg. In the presence of RRR-K-tocopherol acetate (a) these values are 0.94 þ 0.06 mM and 9.05 þ 1.45 Wmol/
minWmg.
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The most probable mechanism of GST inhibition
by tocopherols, K-tocopherol derivatives and arachi-
donic acid is the induction of conformational
changes of the enzyme. These conformational
changes could be caused by volume increases and
structural modi¢cations of lipophilic regions that
are present in the interface between the two mono-
mers of the GST. Binding of a compound to this
region can change the activity of the enzyme [9].
In conclusion, of all tested compounds the toco-
pherols were the most potent inhibitors of GST P1-1.
However, the esteri¢ed tocopherols and the oxidized
product also inhibit the GST P1-1 activity at a very
low concentration (all K-tocopherol esters except all-
rac-K-tocopherol nicotinate exhibit an IC50 value
lower than 10 WM).
Mitchell and McCann [10] found that all-rac-K-to-
copherol is a complete tumor promoter in mouse
skin and Henderson et al. [11] showed that mice
lacking the GST P1-1 have an increased risk for
skin tumorigenesis. These results together with the
fact that GST P1-1 is present in the skin [12] might
be explained by the potent GST P1-1 inhibition.
When vitamin E is added to a product, e.g. a cos-
metic product, mostly a tocopherol ester is used. This
is due to the better chemical stability of the ester
compared to the free tocopherol [13]. Most cosmetic
products, containing a tocopherol ester, are applied
to the skin. GST P1-1 is present mainly in many cells
in the upper layers of the epidermis [14]. To estimate
the maximal concentration of the tocopherol ester in
the skin after application of a cosmetic product we
assume that (i) all the tocopherol ester is transferred
to the epidermis and (ii) the concentration in the
epidermis is one tenth of the concentration in the
cosmetic product. Indeed, Klain found that 4 h after
dermal application of 14C-labeled vitamin E, to hu-
man skin grafted athymic nude mice, the epidermis
contained the most radioactivity. It was suggested
that the skin can act as a reservoir for vitamin E
[15]. Metabolism, elimination, distribution or accu-
mulation due to frequent application of the cosmetic
product is not taken into account in this estimation.
Based on these assumptions it can be calculated that
to reach a concentration of 10 WM of the tocopherol
ester in the epidermis, a concentration inhibiting
GST P1-1 more than 50%, 0.0005% w/v tocopherol
ester in the cosmetic product would be su¤cient. The
concentration in most tocopherol ester containing
cosmetic products exceeds this value by far. Concen-
trations up to 1% can be found; even products con-
taining pure vitamin E are sold. This indicates that
application of a tocopherol ester containing product
on the skin probably results in a substantial inhibi-
tion of GST P1-1. Therefore, a potential tumor pro-
moter e¡ect may also be ascribed to K-tocopherol
esters; however, further research is needed to sub-
stantiate this hypothesis.
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